Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SAL | Ann:Change of Company Name and Code | 09/08/24 | 0 | 342 | |||
|
|||||||
SAL | Ann:Amended Constitution (Price Sensitive) | 09/08/24 | 0 | 389 | |||
|
|||||||
SAL | Ann:Director's Declaration - Vikram Rana (Price Sensitive) | 01/08/24 | 0 | 433 | |||
|
|||||||
SAL | Ann:Results of 2024 AGM | 26/07/24 | 0 | 294 | |||
|
|||||||
SAL | Ann:Officeholder Update | 26/07/24 | 0 | 329 | |||
|
|||||||
SAL | Ann:Vikram Rana | 26/07/24 | 0 | 423 | |||
|
|||||||
SAL | Ann:Results of 2024 AGM | 26/07/24 | 0 | 350 | |||
|
|||||||
SAL | Ann:Comparative Financial Summary | 19/07/24 | 0 | 400 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||